Shares of Atrinsic Inc. (NASDAQ:PTIX – Get Free Report) shot up 15.8% during trading on Thursday . The stock traded as high as $0.22 and last traded at $0.22. Approximately 34,113 shares were traded during mid-day trading, an increase of 5% from the average daily volume of 32,536 shares. The stock had previously closed at $0.19.
Atrinsic Price Performance
The stock’s 50-day moving average is $0.48 and its two-hundred day moving average is $0.58. The stock has a market cap of $470,600.00, a P/E ratio of -0.03 and a beta of 1.01.
Atrinsic Company Profile
Protagenic Therapeutics, Inc, a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound comprises PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. Protagenic Therapeutics, Inc is headquartered in New York, New York.
See Also
- Five stocks we like better than Atrinsic
- Starbucks Builds Sovereign AI to Cut $400 Million in Software Costs
- Power Struggle: Wolfspeed Sues Navitas Over AI Chips
- Why WD-40 Is Proving Great Businesses Never Go Out of Style
- Pushing the Edge: Super Micro Computer Reboots the AI Landscape
Receive News & Ratings for Atrinsic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Atrinsic and related companies with MarketBeat.com's FREE daily email newsletter.
